VEGFA and neoplasm: By acting on erythrocytes through the A2B receptor, ADO increases erythrocyte 2,3-BPG levels and enhances O2-releasing capacity and VEGF production by endothelial cells in the tumor microenvironment, which helps promote tumor angiogenesis35.